Peter Mwethera | Health Professions | Research Excellence Award Published on 28/03/2026 by Environmental Scientists Dr. Peter Mwethera | Health Professions | Research Excellence Award Director General/CEO | The University of Kenya Institute of Primate Research | Kenya Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index
Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems. Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index
Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index
Citation Metrics ( Scopus ) 300 250 200 150 100 50 0 Citations 169 documents 16 h-index 8 Citations Documents h-index
View Scopus Profile View Research Gate Profile Featured Publications Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya – Toxins, 2026
Joaquín María Campos Rosa | Pharmacology | Outstanding Scientist Award Published on 24/03/202628/03/2026 by Environmental Scientists Prof. Joaquín María Campos Rosa | Pharmacology | Outstanding Scientist Award Professor Emeritus of the University of Granada | The University of Granada University | Spain Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index
Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design. Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index
Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index
Citation Metrics ( Scopus ) 4500 3750 3000 2250 1500 750 0 Citations 3894 h-index 34 i10-index 92 Citations Documents h-index
View Google Scholar Profile View ORCID Profile Featured Publications Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models – Journal of Medicinal Chemistry, 2002 Choline kinase inhibitors as a novel approach for antiproliferative drug design – Oncogene, 1997 Homochiral drugs: a demanding tendency of the pharmaceutical industry – Current Medicinal Chemistry, 2009 Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells – Oncogene, 2003 The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner – PLOS ONE, 2011
Dominik Szieber | Virology | Academic Brilliance Recognition Award Published on 20/03/2026 by Environmental Scientists After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 3337 Register Here
Carlo Alberto Pastura | Medicine | Research Excellence Distinction Award Published on 17/03/202617/03/2026 by Environmental Scientists After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 3335 Register Here
Manuel Vazquez-Carrera | Pharmacology | Research Excellence Award Published on 17/03/2026 by Environmental Scientists After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 3331 Register Here
Hooria Shahbaz | Sustainable Sciences | Best Researcher Award Published on 13/03/2026 by Environmental Scientists After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 3327 Register Here
Alpamis Kutlimuratov | Computer Science | Research Excellence Award Published on 13/03/2026 by Environmental Scientists After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 3326 Register Here
Bahar Mehdizadeh | Energy | Women Researcher Award Published on 10/03/2026 by Environmental Scientists After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 3322 Register Here
Emmanouil Nikolaidis | Business | Research Excellence Award Published on 10/03/2026 by Environmental Scientists After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 3320 Register Here
Piera Di Martino | Sustainable | Research Excellence Distinction Award Published on 10/03/2026 by Environmental Scientists After Completing the Registration Process, your Biography will be displayed here. Register by using your Entry ID: 3319 Register Here